Cancer drugs that have been used for two decades were retooled until they were able to eliminate aggressive tumors in a “remarkable” clinical trial.

Two of the patients—one with the deadliest form of skin cancer called melanoma and another with breast cancer—were told their tumors disappeared completely.

Scientists at Rockefeller University in New York engineered an upgrade to an antibody that improved a class of drugs—called CD40 agonist antibodies—which have struggled to make good on their early promise, but showed great potential.

While effectively activating the immune system to kill cancer cells in animal models, the drugs had only “limited” impact on humans, while also triggering dangerous adverse reactions.

So, five years ago, the team at the New York university engineered an en

See Full Page